Washington DC Cannabis: $9.56/g Measured Flower, ~15% Capture, and Eleven Years of Congressional Interference

Washington DC voters approved cannabis legalization in 2014 with 70% of the vote. Eleven years later, the city still has no licensed adult-use market. What it has instead is a medical program that functions as a de facto adult-use channel for anyone willing to register, a "gifting" gray economy that Congress's annual budget rider made structurally inevitable, and — uniquely in this framework — a measured flower price derived directly from published weight and sales data rather than modeled from consumption assumptions. At ~$9.56 per gram, DC's licensed medical channel captures an estimated 15% of resident demand. The other 85% moves through the gifting economy or across the Potomac into Maryland's competitive rec market.

Market Overview

DC voters passed Initiative 71 in November 2014, legalizing adult possession and home cultivation for adults 21 and over. What the initiative couldn't do — because Congress controls DC's budget — was authorize taxed and regulated adult-use sales. The Harris Rider, a provision inserted into federal appropriations bills each year since 2015, has blocked DC from implementing a recreational retail framework for over a decade. What emerged in that gap was the gifting economy: shops that charge for a t-shirt, digital art print, or sticker and "gift" cannabis alongside it. ABCA has been closing those unlicensed operations since 2024, but they persist.

The medical program is the only legal retail channel. The Medical Cannabis Amendment Act of 2022 expanded it significantly — most importantly by allowing DC residents 21 and over to self-certify as patients without a doctor's recommendation. That removed the primary friction barrier and triggered a rapid patient registration surge. By May 2026, the program had 123,826 registered DC residents, up from roughly 94,000 in December 2025.

Key metrics:

• ~$59.4M in 2025 dispensary retail sales (ABCA monthly reports); pace had climbed to $80M+ annualized by May 2026
• ~$9.56/g measured flower price (May 2026, ABCA weight and sales data — directly measured, not modeled)
• ~15% estimated resident capture of BMDE demand (weight-derived from ABCA product data)
• 68 licensed retailers (ABCA, May 2026), including delivery-only operators
• ~13.1 stores per 100,000 adults 21+ on paper; meaningful density overstated by delivery-only licenses and the commuter-population denominator
• ~$874,000 revenue per licensed retailer (2025 total sales ÷ May 2026 retailer count; per-store economics were lower earlier in 2025 before the expansion)
• 6% medical sales tax (current); a proposed increase to 10.25% in Mayor Bowser's FY2027 budget was rejected by the DC Council
• Adults 21+: ~520,000 (estimated; Census Bureau July 2025 total population 693,645, approximate 21+ share ~75%)
• Home cultivation permitted under I-71: up to six plants per adult, no more than three mature; household cap generally 12 plants, six mature

Flower Pricing

DC's flower price is the cleanest number in this framework. The ABCA monthly program reports publish both pounds sold and dollar value by product category — weight and revenue together — which means price per gram is calculated directly rather than derived from a consumption model. In May 2026, licensed DC dispensaries sold 776 pounds of flower/bud for $3,365,547, yielding a measured price of $9.56 per gram. Raw pre-rolls ($13.11/g) and shake/trim ($7.20/g) bookend it. Vape cartridges at roughly $47/unit are the only significant category without a gram-equivalent weight in the published data.

That $9.56/g puts DC near the top of the national price table, in the range of Hawaii, Minnesota, and New York. But unlike those markets, DC's elevated price isn't primarily a function of density constraints or punishing tax structures. It's a function of supply. With no licensed adult-use cultivation buildout permitted by Congress, DC's licensed supply chain is capped at whatever its small cultivator and manufacturer base can produce. There is no commodity-floor dynamic possible in a market where new cultivation licenses can't scale to meet demand. The gifting economy faces the same supply constraints — no licensed wholesale, sourcing through the same informal channels — which is why gifting shops don't consistently undercut the licensed channel on price. An eighth through a gifting operator in DC typically runs $60-70 in "digital art," or roughly $17-20/g equivalent, more expensive than the licensed channel's measured flower price, not less.

Tax Structure

DC's licensed medical cannabis sales carry a 6% sales tax — one of the lighter burdens in any legal jurisdiction. Medical patients get no additional exemption since the program now covers any self-certifying adult 21+, making 6% the standard consumer rate.

Mayor Bowser's FY2027 budget proposed raising the medical cannabis sales tax from 6% to 10.25% under the Medical Cannabis Tax Rate Amendment Act of 2026 — a roughly 70% increase targeting $1.5 million in annual general fund revenue. The DC Council rejected the increase. The episode still matters: DC's own City Council Committee of the Whole warned in its budget review that such an increase "may incentivize District residents to turn to illicit sources that will undoubtedly be cheaper." At a $9.56/g starting price, the margin between the licensed channel and the gifting economy is already thin on convenience grounds. A 70% tax hike would have widened that gap precisely as ABCA is trying to close the gray market through enforcement — and the Council recognized it.

Total Addressable Market

Applying the framework's consumption baseline — 18% participation at 1.0 gram per day — to DC's approximately 520,000 adults 21+:

• ~520,000 adults 21+ (Census Bureau July 2025, 693,645 total × ~75%)
• ~93,600 estimated regular consumers (18%)
• ~34.2 million grams annual resident demand

DC's estimated licensed channel capture: ~15%.

The numerator is measured: ABCA's product-level data shows roughly 420,000-450,000 grams of flower-equivalent moving through licensed dispensaries per month (flower, raw pre-rolls, shake/trim, and concentrates reported by weight). The denominator is modeled — 34.2 million grams of annual resident demand from the framework's 18% participation at 1.0 gram per day. Annualized measured volume against modeled demand yields approximately 15% — a ceiling against the full adult population count.

Revenue Trend

DC's 2025 dispensary sales of ~$59.4 million tell two stories depending on which part of the year you look at. Through February 2025, monthly dispensary retail ran $2.8-2.9 million — a small, mature medical program serving a registered patient base. Then in March 2025, the number of operating dispensaries more than doubled, and monthly retail jumped to $3.7 million and then $5.5 million by April, holding in the $5.2-5.8 million range through year end.

By early 2026 the trajectory had continued — $6.3M in March, $6.5M in April, $6.7M in May, implying an $80M+ annualized pace — driven by the patient registration surge rather than new store openings, with the count holding flat at 68-69 through the period.

Dispensary Density

DC's 68 licensed retailers against roughly 520,000 adults 21+ yields a density of approximately 13 stores per 100,000 on paper — but revenue per store tells a more honest story. At roughly $874,000 annually in 2025, DC dispensaries are among the lowest-earning in the framework for their density, far below comparable markets.

DC's combination of moderate-to-high density and low revenue per store is the inverse of every high-capture market in the table — a signature of a channel serving only a fraction of actual demand.

Home Cultivation

I-71 permits DC residents to grow up to six plants per adult, no more than three mature — with a household cap generally of 12 plants, six mature — without registration, available to all adults 21+. At nearly $10/g for licensed flower, the home-grow economics are more compelling than in commodity-floor markets, but the city's apartment-dense housing stock limits how many residents can meaningfully exercise the right.

The Harris Rider and the Gifting Economy

The structural fact that defines DC's cannabis market above all others is that Congress blocked implementation of what voters approved. The Harris Rider — a spending restriction inserted into federal appropriations bills each year since 2015 — prevents DC from using funds to enact adult-use retail sales, the natural endpoint of Initiative 71. It's prohibited not by DC's own government but by members of Congress who don't represent DC residents.

What grew in that vacuum is the gifting economy — hundreds of shops selling a nominal item and gifting cannabis alongside it, operating in the gray space I-71 created. ABCA and MPD have been systematically closing them since new civil enforcement powers took effect in July 2024. Since then, 113 illegal cannabis businesses have been padlocked. The closures appear to be driving the licensed patient registration surge: DC resident registrations grew from roughly 94,000 in December 2025 to 123,826 by May 2026 — nearly 30,000 new patients in five months. The licensed channel is growing, but it's absorbing gifting market refugees, not converting previously illicit consumers — a different dynamic than the standard medical-to-adult-use conversion seen elsewhere.

The Bottom Line

DC is the only jurisdiction in this framework where the gap between what voters approved and what the law permits is measured not in policy lag but in a decade-plus of Congressional interference. Voters chose legalization in 2014. The licensed channel captures an estimated 15% of resident demand in 2026. The remaining demand is presumably split among the gifting economy, traditional illicit supply, home grow and social supply, and cross-border purchases in Maryland.

The measured flower price of $9.56/g reflects what happens when supply is constitutionally capped: no competitive cultivation buildout, no commodity-floor pricing, no margin pressure from a legal recreational sector that isn't allowed to exist. The Council's rejection of the proposed 10.25% tax increase — after its own budget committee warned it would push patients toward unlicensed sources — shows that even DC's own government recognizes how fragile the licensed channel's price position is.

What DC's market actually needs isn't a higher tax on the 15% of demand the licensed channel captures. It's authorization to capture the other 85%.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.